Bealka N, Schwartz B
Department of Ophthalmology, New England Medical Center Hospitals, Boston, MA 02111.
Arch Ophthalmol. 1991 Mar;109(3):346-8. doi: 10.1001/archopht.1991.01080030048036.
In 12 patients with ocular hypertension and similar pressures in each eye, one eye was randomly selected in a masked manner for pretreatment with three applications of topical 0.01% dexamethasone sodium phosphate drops prepared in artificial tears. The other eye was treated with three applications of drops of artificial tears alone. Both eyes were then treated with 0.1% epinephrine hydrochloride drops. Ocular pressures were measured for the next 2 hours at 20-minute intervals. When compared with eyes treated with epinephrine drops alone, eyes pretreated with dexamethasone drops showed a significantly greater decrease in pressure (mean [+/- SD] maximum difference, 3.1 +/- 2.1 mm Hg). Five patients had a difference of 1.0 to 4.0 mm Hg and five patients had a difference of 4.0 to 6.0 mm Hg. Two patients showed no response. Younger age was associated with the greater response. Adrenergic-glucocorticoid synergism resulting in the lowering of ocular pressure may offer a potential for therapeutic use in ocular hypertension and glaucoma.
在12例双眼眼压高且眼压相近的患者中,以盲法随机选择一只眼睛,用人工泪液配制的0.01%地塞米松磷酸钠滴眼液局部给药3次进行预处理。另一只眼睛仅用人工泪液滴眼液给药3次。然后两只眼睛均用0.1%盐酸肾上腺素滴眼液治疗。在接下来的2小时内,每隔20分钟测量一次眼压。与仅用肾上腺素滴眼液治疗的眼睛相比,用地塞米松滴眼液预处理的眼睛眼压下降明显更大(平均[±标准差]最大差值为3.1±2.1 mmHg)。5例患者的差值为1.0至4.0 mmHg,5例患者的差值为4.0至6.0 mmHg。2例患者无反应。年龄较小与反应较大相关。肾上腺素-糖皮质激素协同作用导致眼压降低,这可能为高眼压症和青光眼的治疗提供潜在应用。